147 related articles for article (PubMed ID: 37991563)
1. Treatment Effect of Zoledronic Acid in Chronic Non-bacterial Osteomyelitis of the Jaw: A Case Series.
Jansen RB; Nilsson J; Buch-Larsen K; Kofod T; Schwarz P
Calcif Tissue Int; 2024 Feb; 114(2):129-136. PubMed ID: 37991563
[TBL] [Abstract][Full Text] [Related]
2. Dealing with Chronic Non-Bacterial Osteomyelitis: a practical approach.
Taddio A; Ferrara G; Insalaco A; Pardeo M; Gregori M; Finetti M; Pastore S; Tommasini A; Ventura A; Gattorno M
Pediatr Rheumatol Online J; 2017 Dec; 15(1):87. PubMed ID: 29287595
[TBL] [Abstract][Full Text] [Related]
3. Chronic Non-bacterial Osteomyelitis: A Review.
Buch K; Thuesen ACB; Brøns C; Schwarz P
Calcif Tissue Int; 2019 May; 104(5):544-553. PubMed ID: 30456556
[TBL] [Abstract][Full Text] [Related]
4. Ibandronate treatment of diffuse sclerosing osteomyelitis of the mandible: Pain relief and insight into pathogenesis.
Otto S; Troeltzsch M; Burian E; Mahaini S; Probst F; Pautke C; Ehrenfeld M; Smolka W
J Craniomaxillofac Surg; 2015 Nov; 43(9):1837-42. PubMed ID: 26421465
[TBL] [Abstract][Full Text] [Related]
5. A case of bone destruction caused by chronic non-bacterial osteomyelitis (CNO) successfully repaired with a tumour necrosis factor-α (TNF-α) inhibitor, adalimumab.
Kanda R; Nakano K; Miyagawa I; Iwata S; Nakayamada S; Tanaka Y
Mod Rheumatol Case Rep; 2020 Jul; 4(2):196-201. PubMed ID: 33087018
[TBL] [Abstract][Full Text] [Related]
6. Treatment Response and Longterm Outcomes in Children with Chronic Nonbacterial Osteomyelitis.
Schnabel A; Range U; Hahn G; Berner R; Hedrich CM
J Rheumatol; 2017 Jul; 44(7):1058-1065. PubMed ID: 28461645
[TBL] [Abstract][Full Text] [Related]
7. Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases.
Ikesue H; Mouri M; Tomita H; Hirabatake M; Ikemura M; Muroi N; Yamamoto S; Takenobu T; Tomii K; Kawakita M; Katoh H; Ishikawa T; Yasui H; Hashida T
Support Care Cancer; 2021 Aug; 29(8):4763-4772. PubMed ID: 33527228
[TBL] [Abstract][Full Text] [Related]
8. Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.
Himelstein AL; Foster JC; Khatcheressian JL; Roberts JD; Seisler DK; Novotny PJ; Qin R; Go RS; Grubbs SS; O'Connor T; Velasco MR; Weckstein D; O'Mara A; Loprinzi CL; Shapiro CL
JAMA; 2017 Jan; 317(1):48-58. PubMed ID: 28030702
[TBL] [Abstract][Full Text] [Related]
9. Zoledronic acid: a review of its use in the management of bone metastases and hypercalcaemia of malignancy.
Wellington K; Goa KL
Drugs; 2003; 63(4):417-37. PubMed ID: 12558465
[TBL] [Abstract][Full Text] [Related]
10. A standardized clinical and radiological follow-up of patients with chronic non-bacterial osteomyelitis treated with pamidronate.
Hofmann C; Wurm M; Schwarz T; Neubauer H; Beer M; Girschick H; Morbach H
Clin Exp Rheumatol; 2014; 32(4):604-9. PubMed ID: 25065777
[TBL] [Abstract][Full Text] [Related]
11. [Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project].
Dalle Carbonare L; Bertoldo F; Lo Cascio V
Reumatismo; 2009; 61(1):54-64. PubMed ID: 19370189
[TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis of the jaw among patients with cancer treated with denosumab or zoledronic acid: Results of a regulator-mandated cohort postauthorization safety study in Denmark, Norway, and Sweden.
Ehrenstein V; Heide-Jørgensen U; Schiødt M; Akre O; Herlofson BB; Hansen S; Larsson Wexell C; Nørholt SE; Tretli S; Kjellman A; Glennane A; Lowe KA; Sørensen HT
Cancer; 2021 Nov; 127(21):4050-4058. PubMed ID: 34310704
[TBL] [Abstract][Full Text] [Related]
13. Chronic non-bacterial osteomyelitis in the jaw.
Kim SM; Lee SK
J Korean Assoc Oral Maxillofac Surg; 2019 Apr; 45(2):68-75. PubMed ID: 31106134
[TBL] [Abstract][Full Text] [Related]
14. Chronic Nonbacterial Osteomyelitis of the Jaw in a 3-Year-Old Girl.
Makino S; Oshige H; Shinozuka J; Imashuku S
Pediatr Rep; 2023 Mar; 15(1):209-214. PubMed ID: 36976723
[TBL] [Abstract][Full Text] [Related]
15. Aggressive Therapy Reduces Disease Activity without Skeletal Damage Progression in Chronic Nonbacterial Osteomyelitis.
Zhao Y; Chauvin NA; Jaramillo D; Burnham JM
J Rheumatol; 2015 Jul; 42(7):1245-51. PubMed ID: 25979712
[TBL] [Abstract][Full Text] [Related]
16. Chronic nonbacterial osteomyelitis in children: a multicenter case series.
Concha S; Hernández-Ojeda A; Contreras O; Mendez C; Talesnik E; Borzutzky A
Rheumatol Int; 2020 Jan; 40(1):115-120. PubMed ID: 31375886
[TBL] [Abstract][Full Text] [Related]
17. First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.
Morgan GJ; Davies FE; Gregory WM; Cocks K; Bell SE; Szubert AJ; Navarro-Coy N; Drayson MT; Owen RG; Feyler S; Ashcroft AJ; Ross F; Byrne J; Roddie H; Rudin C; Cook G; Jackson GH; Child JA;
Lancet; 2010 Dec; 376(9757):1989-99. PubMed ID: 21131037
[TBL] [Abstract][Full Text] [Related]
18. Chronic Diffuse Sclerosing Osteomyelitis of the Mandible: The Use of Bisphosphonates as a Treatment for a Rare and Challenging Condition.
Keller E; Clocchiatti S; Rupel K; Ottaviani G; Ratti C; Canton G; Di Lenarda R; Murena L; Biasotto M
Medicina (Kaunas); 2024 May; 60(6):. PubMed ID: 38929534
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial.
Amadori D; Aglietta M; Alessi B; Gianni L; Ibrahim T; Farina G; Gaion F; Bertoldo F; Santini D; Rondena R; Bogani P; Ripamonti CI
Lancet Oncol; 2013 Jun; 14(7):663-70. PubMed ID: 23684411
[TBL] [Abstract][Full Text] [Related]
20. Response to Early-onset Pamidronate Treatment in Chronic Nonbacterial Osteomyelitis: A Retrospective Single-center Study.
Andreasen CM; Jurik AG; Glerup MB; Høst C; Mahler BT; Hauge EM; Herlin T
J Rheumatol; 2019 Nov; 46(11):1515-1523. PubMed ID: 30988129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
